Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eribulin mesylate in metastatic or recurrent SCCHN
NCT00337129Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2006
- Primary completion
- Aug 2008
- Countries
- 1
01
Overview
A Phase 2 trial of eribulin in squamous cell carcinoma of the head and neck (HNSCC), sponsored by National Cancer Institute. Started May 2006; status: completed.
02
Drugs
eribulin
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT00337129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337129.